Early Flu Season Activity Climbs as H1N1 Dominates Lab Detections
CDC surveillance data show influenza activity higher than typical for early November, with Washington state public health laboratories confirming two new H5 infections.
Category: Emerging & Zoonotic Diseases
Emerging & Zoonotic Diseases
Latest
Emerging & Zoonotic Diseases
Latest
FDA Grants EUA for Multiplex PCR Assay for Viral Skin Lesions
The assay from Seegene USA simultaneously detects and differentiates herpes simplex virus, varicella-zoster virus, and monkeypox virus.
Emerging & Zoonotic Diseases
Latest
Oropouche Virus Test Introduced by Quest Diagnostics
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
Health Alliance Validates Bird Flu Test for Outbreak Preparedness
The Health Alliance validated a bird flu PCR assay for human diagnostics, a tool for early detection of avian influenza outbreaks.
Read More
Labcorp Launches H5 Bird Flu Test
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read More
New Diagnostic Kit for Rapid H5N1 Avian Influenza Detection
Researchers developed an advanced diagnostic kit enabling rapid detection and differentiation of H5N1 avian influenza strains.
Read More
New Optical Biosensor Detects Mpox in Minutes
Researchers developed an optical biosensor that rapidly identifies mpox, enabling quicker, more accessible diagnoses at the point of care.
Read More
Alveo Technologies Partners with CDC to Advance Rapid Avian Flu Diagnostics
Alveo Technologies secured a CDC agreement to develop a test for detecting and differentiating between Influenza A, B, and A/H5.
Read More
Malaria Test Could Be Global Game Changer
A new noninvasive malaria test can detect malaria-infected cells in the bloodstream without requiring a blood sample.
Read More
Quest Secures CDC Contracts for Testing Readiness of Avian Influenza and Oropouche Viruses
Quest Diagnostics was awarded contracts by the CDC to support testing and sustained laboratory readiness for emerging infectious diseases.
Read More
New Test Offers Improved Lyme Disease Detection with 90% Accuracy
The Lyme disease test is capable of detecting the disease at all stages, including within 14 days of infection, with over 90% accuracy.
Read More
Abbott Survey Reveals Gaps in Pandemic Preparedness
Abbott’s Pandemic Preparedness Survey found significant gaps remain in surveillance programs and testing infrastructure capabilities.
Read More
ARUP Labs Partners with CDC to Develop H5N1 Test
ARUP Laboratories has been selected by the CDC to develop a rapid-response test for H5N1, addressing the ongoing public health crises.
Read More
Virax Biolabs Expands Mpox Test Distribution Agreement with Cosmos Health
Virax Biolabs extended its distribution agreement with Cosmos Health to commercialize its Mpox kits in the Gulf Cooperation Council.
Read More
Lyme Disease ImmunoBlot Test Gets FDA Clearance
ID-FISH Technology’s new test for the detection of IgG antibodies against Borrelia-causing Lyme disease has received FDA clearance.
Read More
Roche Enhances Response to Mpox Outbreak with Advanced Diagnostic Tests
Roche announced its continued support in addressing the global mpox emergency by partnering with healthcare providers and organizations.
Read More
Alveo Technologies’ Rapid Avian Influenza Test Detects Latest H5N1 Variants
Alveo Technologies’ handheld molecular diagnostic tool can detect the H5N1 avian influenza variant based on recent infection sequences.
Read More
New Test Helps Diagnose Chagas Disease in Newborns
Researchers developed a test for early detection of T. cruzi infection in newborns, showing promise for better management of Chagas disease.
Read More